FDA Approves Prevnar 13 Pneumococcal Disease Vaccine
Links shared publicly online about this topic
FDA Approves Prevnar 13 Pneumococcal Disease Vaccine
drugs.com — “Prevnar 13 (pneumococcal 13-valent conjugate vaccine) is used for prophylaxis of pneumococcal disease. Includes Prevnar 13 side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 26, 2010 at 1:03 am By:
FDA Approves Prevnar 13 Pneumococcal Disease Vaccine - http://bit.ly/cx9k4D
FDA Approves Pneumococcal Disease Vaccine with Broader Protection
fda.gov — “The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.” View full resource at fda.gov
Most Recently Shared on February 24, 2010 at 6:31 pm By:
Len Leshin Physician, Doctor, and Pediatrician
FDA approves new #Pneumococcal Vaccine with Broader Protection for infants, toddlers http://bit.ly/9as7JB #pediatrics #Prevnar
FDA Approves Pneumococcal Disease Vaccine With Broader Protection
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor” View full resource at medicalnewstoday.com
Most Recently Shared on February 25, 2010 at 2:55 pm By:
FDA Approves Pneumococcal Disease Vaccine With Broader Protection The U.S. Food and Drug Administration approved Prev.. http://bit.ly/adkhzF
FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine
news-medical.net — “Pfizer Inc. announced today that the United States Food and Drug Administration has granted approval for Prevnar 13" (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the Company's 13-valent pneumococcal conjugate vaccine.” View full resource at news-medical.net
Most Recently Shared on February 25, 2010 at 5:38 am By:
FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine: Pfizer Inc. announced today that the United State... http://bit.ly/bOQF86
Pfizer Receives FDA Approval For Prevnar 13™ For The Prevention Of Invasive Pneumococcal Disease In Infants And Young Children
medicalnewstoday.com — “Pfizer Inc. (NYSE:PFE) announced today that the United States Food and Drug Administration (FDA) has granted approval for Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CR” View full resource at medicalnewstoday.com
Most Recently Shared on February 26, 2010 at 2:16 pm By:
MNT Pediatrics News Pediatrics and Health News
Pfizer Receives FDA Approval For Prevnar 13™ For The Prevention Of Invasive Pneumococcal Disease In Infants And ... http://mnt.to/3y8Z
Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal disease
news-medical.net — “Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.” View full resource at news-medical.net
Most Recently Shared on December 23, 2010 at 10:36 am By:
Meningitis News: Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal disease: Pfiz... http://bit.ly/eq2rKO
Health Canada approves Prevnar 13 vaccine for invasive pneumococcal disease
news-medical.net — “Following a Priority Review, Health Canada has approved Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)) for children aged six weeks through five years for active immunization against invasive pneumococcal disease, a bacterial infection that can include meningitis (inflammation of the coverings of the brain and spinal cord), sepsis (bloodstream infection), bacteremic pneumonia, pleural empyema (accumulation of pus in the cavity surrounding the lungs) and bacterem” View full resource at news-medical.net
Most Recently Shared on December 24, 2009 at 2:02 am By:
Meningitis News: Health Canada approves Prevnar 13 vaccine for invasive pneumococcal disease: Following a Priority ... http://bit.ly/58SP9P
FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults
news-medical.net — “Pfizer Inc. announced today that the U.S. Food and Drug Administration has granted approval of the Company's pneumococcal conjugate vaccine Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) as a single dose for use in adults.” View full resource at news-medical.net
Most Recently Shared on December 31, 2011 at 9:55 am By:
Meningitis News: FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults: Pf... http://t.co/4eorFS2i
FDA approves Prevnar 13; ACIP issues recommendations for use
pediatricsupersite.com — “The FDA today approved Pfizer’s Prevnar 13, indicated for the active immunization of children to prevent invasive disease caused by Strepto” View full resource at pediatricsupersite.com
Most Recently Shared on February 24, 2010 at 8:35 pm By:
Pediatric SuperSite Health Site
FDA approves Prevnar 13; ACIP issues recommendations for use: http://ow.ly/1aVtz
Symposier - New Pneumococcal Vaccine for Children
symposier.com — “Uploaded and Shared in Youtube by: USFoodandDrugAdmin FDA has approved a new pneumococcal vaccine that provides broader protection for infants and young children ages six weeks through five years. The new vaccine, called Prevnar 13, is effective against 13 serotypes of the bacterium Streptococcus pneumoniae. It will replace Prevnar, which was effective against seven serotypes. Prevnar 13 is approved to prevent invasive pneumococcal disease, including bacterial meningitis and bacteremia, caused b” View full resource at symposier.com
Most Recently Shared on May 21, 2010 at 6:04 pm By:
FDA - New Pneumococcal Vaccine for Children. http://bit.ly/cML6lF
FDA panel supports Pfizer vaccine Prevnar 13 - Related Stories - AAP SmartBrief
smartbrief.com — “An FDA panel deemed Prevnar 13 safe and effective in preventing pneumococcal diseases in children despite concerns that the vaccine did not outperform the original Prevnar for three strains of bacteria during trials. Pfizer stands by its data, which show Prevnar 13 protects against more strains comp” View full resource at smartbrief.com
Most Recently Shared on November 20, 2009 at 2:10 am By:
Clara Song Pediatrician, Physician, and Doctor
FDA panel supports Pfizer vaccine Prevnar 13 http://sbne.ws/r/3jfu
UPDATE 2-US panel backs Pfizer's newer Prevnar vaccine | Reuters
reuters.com — “* FDA panel: Pfizer's Prevnar 13 safe, effective * FDA decision due by late December * Pfizer shares gain 1.4 pct (Recasts; Adds panel member quotes) By Lisa Richwine BETHESDA, Md., Nov 18 (Reuters)” View full resource at reuters.com
Most Recently Shared on November 19, 2009 at 1:01 am By:
US panel backs Pfizer's newer Prevnar vaccine - Reuters - MiamiHerald.comUS panel backs Pfizer's newer Prevnar ... http://ow.ly/162I1P
FDA Greenlights Pneumonia Vaccine
medicalnewstoday.com — “The FDA has approved Prevnar 13, for use on people over 50. Prevnar 13 is a pneumococcal 13-valent conjugate vaccine, that can prevent pneumonia and disease caused by the bacterium, Streptococ” View full resource at medicalnewstoday.com
Most Recently Shared on January 2, 2012 at 6:05 pm By:
MedicalNewsToday: FDA Greenlights Pneumonia Vaccine http://t.co/CVwo11L4 Full http://t.co/XexlS93r
Supplemental NDA submitted for Prevnar 13 in older adults - MPR
empr.com — “Pfizer announced that it has submitted a supplemental NDA (sNDA) to the FDA to expand the use of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.” View full resource at empr.com
Most Recently Shared on December 23, 2010 at 6:23 pm By:
MPR News: Supplemental NDA submitted for Prevnar 13 in older adults: Pfizer announced that it has submitted a su... http://bit.ly/f9E30H
FDA weighs updated kids’ pneumococcal shot - Kids and parenting- msnbc.com
msnbc.msn.com — “The Food and Drug Administration is weighing whether to approve an updated version of Pfizer's best-selling anti-infection vaccine for children, despite company studies that failed to meet certain goals.” View full resource at msnbc.msn.com
Most Recently Shared on November 16, 2009 at 6:55 pm By:
msnbc.com - Health Health News
FDA weighs updated anti-infection shot for kids http://bit.ly/3JvqXL
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Len Leshin
Husband, father to two boys, one with Down syndrome. Practicing pediatrician.
-
medical_tweets
Advertisement
